ITGAM and neoplasm: In this study, we found that SLR14 i.t. treatment induced an increase of cytotoxic CD8+ T lymphocytes not only in tumor but also in the dLN, and an increase in CD11b+ cells containing SLR14 in the dLN (but not in the ndLN).